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Endothelial cells exhibit distinct properties in morphology and functions in different organs that 
can be exploited for nanomedicine targeting. In this work, endothelial cells from different 
organs, i.e. brain, lung, liver, and kidney, were exposed to plain, carboxylated, and amino-
modified silica. As expected, different protein coronas were formed on the different 5 
nanoparticle types and these changed when foetal bovine serum (FBS) or human serum were 
used. Uptake efficiencies differed strongly in the different endothelia, confirming that the cells 
retained some of their organ-specific differences. However, all endothelia showed higher 
uptake for the amino-modified silica in FBS, but, interestingly, this changed to the carboxylated 
silica when human serum was used, confirming that differences in the protein corona affect 10 
uptake preferences by cells. Thus, uptake rates of fluid phase markers and transferrin were 
determined in liver and brain endothelia to compare their endocytic activity. Overall, our results 
showed that endothelial cells of different organs have very different nanoparticle uptake 
efficiency, likely due to differences in receptor expression, affinity, and activity. A thorough 
characterization of phenotypic differences in the endothelia lining different organs is key to the 15 
development of targeted nanomedicine. 
1. Introduction 
Nano-sized materials hold tremendous potential as drug carriers, thanks to their ability to 
distribute within organisms and enter cells (Bareford and Swaan, 2007; Ferrari, 2005; Peer et 
al., 2007; Sahay et al., 2010). Although their use as carriers of therapeutic agents has been 20 
growing rapidly during the past decades, crucial questions still arise as to how nanoparticles 
can be effectively and selectively delivered to their target. In order to reach their target tissue, 
following administration into the bloodstream, nano-sized drug carriers, in most cases, first 
need to interact with and cross endothelial cell barriers. Due to the diversity in vascular channels 




— endothelial cells lining blood vessels of different organs exhibit very distinct properties in 
morphology and functions (Aird, 2012; Chi et al., 2003; Ribatti et al., 2002). Consequently, 
these differences provide a great opportunity to selectively target drug carriers to specific 
endothelial cell barriers (Ding et al., 2006; Kowalski et al., 2013; Muro et al., 2008; Simone et 
al., 2009). 30 
To date, most efforts in nanomedicine targeting have been devoted to understanding the effect 
of different physicochemical properties of nanoparticles and the environment in which they are 
applied on their interaction with cells. Several nanoparticles properties such as the size 
(Chithrani et al., 2006; He et al., 2010; Rejman et al., 2004), shape (Chithrani et al., 2006), 
surface charge (Arvizo et al., 2010; He et al., 2010), and (core) materials (Georgieva et al., 35 
2011), as well as environmental properties such as protein composition of the biological fluids 
in which they are dispersed (Lesniak et al., 2012), pH (Shen et al., 2008), temperature, flow 
(Freese et al., 2017) and shear stress (Klingberg et al., 2015) have been shown to have a 
significant influence on nanoparticle-cell interactions. However, relatively less attention has 
been paid on differences in cellular properties, which can affect nanoparticle-cell interactions. 40 
For instance, we have previously shown that a specific cell type can show very different 
nanoparticle uptake behavior when it is developed into a polarized cell monolayer, i.e., a cell 
barrier, as opposed to confluent cells (Francia et al., 2018; Zuhorn et al., 2007). The 
development of cells into cell barriers reduced the gene expression levels of different protein 
markers and/or caused their relocation to the abluminal plasma membrane, resulting in lower 45 
uptake efficiency of luminally applied nanoparticles. It is known that polarized cell barriers 
express different uptake pathways and receptors on their apical and basal side, and this can 
affect nanoparticle uptake (Georgieva et al., 2011; Iversen et al., 2011; Wang et al., 2016). 
Similarly, because of their phenotypical heterogeneity, endothelial cells of different tissue 




exploited for nanomedicine targeting. As an example, a recent study showed that kidney 
glomerulus and blood-brain barrier had a distinct nanoparticle uptake behavior (Gromnicova et 
al., 2016). In addition to a different origin, heterogeneity induced by physiological stress can 
also lead to the expression of different proteins on endothelial cells, and these have been shown 
to be excellent targets for drug carriers (Ding et al., 2006; Kowalski et al., 2013, 2011). 55 
The aim of this study was to investigate the cellular uptake behavior of nanoparticles on 
endothelial barriers generated from endothelial cells derived from different organs. We 
hypothesized that different endothelia would show preferential uptake for certain types of 
nanoparticles, and similar differences could be exploited for targeting. To test this hypothesis, 
four endothelial cell lines derived from different organs were chosen as endothelial cell models: 60 
hCMEC/D3 (brain), HPMEC-ST1.6R (lung), TRP3 (liver), and ciGENC (kidney). The 
selection of these organs was based on the high phenotypic differences between one another. 
In addition, the selected immortalized endothelial cell lines have been shown to be excellent 
models of the endothelia of the respective organ from which they were derived, since they 
retained their organ-specific properties in vitro.(Krump-Konvalinkova et al., 2001; Parent et 65 
al., 2014; Satchell et al., 2006; Weksler et al., 2005) The exhibition of organ-specific 
characteristics of the cell lines in vitro was essential for this comparative study. Amorphous 
silica nanoparticles of 100 nm with three different surface functionalizations, plain, 
carboxylated and amino-modified, were used as representative model nanoparticles. It is known 
that surface properties affect corona formation on the nanoparticles in serum and this, in turn, 70 
affects nanoparticle recognition by cell receptors and uptake by cells (Caracciolo et al., 2017, 
2013; Francia et al., 2019; Lara et al., 2017; Lundqvist et al., 2008; Ritz et al., 2015; Tenzer et 
al., 2013). We hypothesized that due to varying coronas, the different nanoparticles would 
naturally target specific organ endothelia. Therefore, cell culture conditions were optimized to 




in the organ-specific endothelia in order to determine differences in uptake behavior. Finally, 
the rate of endocytosis of fluid phase markers and transferrin in the blood brain barrier and the 
liver sinusoids were compared in order to identify potential differences which may account for 
different uptake efficiency of nanoparticles in these cells. 
2. Methods 80 
2.1 Cell culture 
The immortalized human brain endothelial cell line, hCMEC/D3, was supplied by Pierre-
Olivier Couraud (Weksler et al., 2005). Cells were cultured in standard cell culture flasks pre-
coated with 0.1 mg/ml cold rat-tail collagen type-I (Corning, NY, USA) in an endothelial basal 
medium (EBM-2, LONZA, Allendale, NJ, USA) supplemented with 5% fetal bovine serum 85 
(FBS, Gibco Thermofisher Scientific, Landsmeer, Netherlands), 200 ng/ml bFGF (Peprotech, 
London, United Kingdom), 1 µg/ml hydrocortisone (Sigma-Aldrich, St Luis, USA), 1% 
chemically defined lipid concentrate (Thermofisher Scientific), and 10 mM HEPES 
(Thermofisher Scientific). The medium was refreshed every 2-3 days, and cells were cultured 
between passages 29-38. Cells were kept under standard conditions (37˚C, 5% CO2). 90 
The immortalized human pulmonary microvascular endothelial cell line, HPMEC-ST1.6R, was 
supplied by Ronald E. Unger (Krump-Konvalinkova et al., 2001). Cells were cultured in 
standard cell culture flasks pre-coated with 0.2% cold gelatin (Sigma-Aldrich) in an EBM-2 
supplemented with an EGM-2 bullet kit (LONZA). The medium was refreshed every 2-3 days, 
and cells were kept under standard conditions (37˚C, 5% CO2). 95 
The immortalized human liver endothelial sinusoidal cell line, TRP3, was supplied by Birke 
Bartosch and Romain Parent (Parent et al., 2014). Cells were cultured in standard cell culture 
flasks pre-coated with 0.1% cold gelatin (Sigma-Aldrich) in an MCDB 131 medium (Gibco 




glutamine (Thermofisher Scientific), 250 µg/ml cAMP (Sigma-Aldrich),1 µg/ml 100 
hydrocortisone (Sigma-Aldrich), and 50 µg/ml endothelial cell growth supplement (ECGS, 
Corning). The medium was refreshed every 2-3 days, and cells were kept under standard 
conditions (37˚C, 5% CO2). 
The conditionally immortalized glomerular endothelial cell line, CiGENC, was supplied by 
Simon Satchell (Satchell et al., 2006). Cells were cultured in standard cell culture flasks pre-105 
coated with 1 µg/cm2 fibronectin (Corning) in an EBM-2MV supplemented with an EGM-2MV 
bullet kit (LONZA), with the exception of VEGF, which was not added to the medium. The 
medium was refreshed every 2-3 days. Cells were kept at 33˚C with 5% CO2 until they were 
90% confluent. 
2.2 Endothelial cell barrier formation 110 
An endothelial cell barrier with each cell line was obtained by seeding 25,000 cells/cm2 for 
HPMEC-ST1.6R, or 50,000 cells/cm2 for the other cell lines, respectively, in a 24-well plate 
(Corning) pre-coated as described above. The cells were cultured for an additional three days 
for ciGENC and TRP3, or four days for hCMEC/D3 and HPMEC-ST1.6R, respectively, and 
kept under standard conditions (37˚C, 5% CO2). The medium was refreshed every two days. 115 
2.3 Immunohistochemistry 
Cell confluency and morphology were assessed by light microscopy (Olympus IX50). For 
immunohistochemistry, 25000 cells/cm2 for HPMEC-ST1.6R or 50000 cells/cm2 for the other 
cell lines, respectively, were seeded in a 24-well plate (Corning) on glass coverslips pre-coated 
as described above for each cell line. Three days after seeding, for ciGENC and TRP3, or four 120 
days for hCMEC/D3 and HPMEC-ST1.6R, respectively, cells were fixed with formaldehyde 
(4% v/v) solution for 15 minutes and then permeabilized with Triton X-100 (0.1% v/v) for 5 




occludens-1 (ZO-1, Life technologies, NY, USA) and CD31 (also known as platelet endothelial 
cell adhesion molecule, PECAM1, Dako, Glostrup, Denmark) for 1 hour at room temperature, 125 
followed by incubation with Alexa Fluor 488- (Life Technologies, NY, USA) and Cy5- labelled 
(Jackson Immuno Research Laboratories, Inc., PA, USA) secondary antibodies for 1 hour. 
Nuclear staining was performed by incubating cells for 5 minutes with 0.2 ug/ml 4’,6-
diamidino-2-phenylindole (DAPI). Afterwards, slides were mounted with Mowiol 4-88 
mounting medium (EMD Chemical, Inc., CA, USA). Fluorescence imaging was performed 130 
using a Leica TCS SP8 confocal fluorescence microscope (Leica Microsystems, Wetzlar, 
Germany) with a 405 nm laser for DAPI excitation, a 488 nm laser for Alexa Fluor 488, and 
638 nm laser for Cy5. Images were processed using ImageJ software (http://www.fiji.sc). 
Brightness was adjusted to improve visualization. 
2.4 Nanoparticle characterization  135 
Green fluorescently labeled (maximum excitation and emission wavelength 485 and 510 nm, 
respectively) plain (non-functionalized, SiO2), amino-modified (SiO2-NH2), and carboxylated 
silica nanoparticles (SiO2-COOH) of 100 nm were purchased from Micromod 
Partikeltechnologie GmbH (Rostock, Germany). Nanoparticle size distribution by dynamic 
light scattering (DLS) and zeta potential (ζ-potential) were measured using a Malvern Zetasizer 140 
Nano ZS (Malvern Instrument Ltd., Worcestershire, UK). Briefly, nanoparticles (100 µg/ml) 
were dispersed in PBS, dH2O or cell culture medium supplemented with 5 mg/ml FBS (Gibco
 
Thermofisher Scientific), corresponding to the standard 10% v/v cell culture medium, or the 
same amount of human serum (human serum from pooled donors, from TCS BioSciences Ltd 
Botolph Claydon, Buckingham, UK). Samples were measured at 20˚C immediately, or after 145 
24-hour incubation at 37˚C using disposable capillary cells (Malvern). The results are the 




2.5 Nanoparticle uptake and flow cytometry analysis 
Cell fluorescence intensity was used as a measurement of nanoparticle uptake on the endothelial 
cell barriers. Briefly, after developing cell barriers as described above, cells were exposed for 150 
1, 3, 5, 24, and 26 hours to 50 µg/ml SiO2, SiO2-NH2, or SiO2-COOH. Nanoparticles were 
dispersed at room temperature in cell culture medium containing 5 mg/ml FBS (Gibco 
Thermofisher Scientific) or human serum (TCS BioSciences). Cells were exposed to the freshly 
prepared nanoparticle dispersions immediately after mixing by replacing the cell culture 
medium. After exposure, in order to remove the excess of nanoparticles and reduce the presence 155 
of nanoparticles adhering outside the cell membrane which could interfere with uptake 
quantification, cells were washed once with cell culture medium supplemented with 10% FBS 
(Gibco Thermofisher Scientific) and twice with PBS. Afterwards, cells were detached using 
0.05% trypsin-EDTA. Cell fluorescence was measured using a Cytoflex S Flow Cytometer 
(Beckman Coulter, Woerden, The Netherlands) with a 488 nm laser. Data were analyzed by 160 
Flowjo data analysis software (Flowjo, LLC). Dead cells and cell doublets were excluded from 
the plots by setting gates in the forward and side scattering double scatter plots. At least 15,000 
cells were acquired per sample, and the median of the obtained cell fluorescence distribution 
calculated. For each exposure time, duplicate samples were made and their median cell 
fluorescence intensity is shown, together with their average. The results of an independent 165 
replicate experiment are shown in Supplementary Figures S2-3 to confirm the trends observed.  
2.6 Nanoparticle-corona formation and characterization 
In order to examine the corona formed on the different nanoparticles, 1 mg/ml SiO2, SiO2-NH2, 
or SiO2-COOH of 100 nm size were dispersed in PBS containing 5 mg/ml FBS (Gibco
 
Thermofisher Scientific) or human serum (TCS BioSciences) and incubated at 37˚C under 170 
continuous shaking at 300 rpm for 1 hour. After this, the dispersion was centrifuged for 1 hour 




and centrifuged again for 1 hour at 16,000 g for a total of three centrifugations to remove the 
soft serum corona and excess free proteins in solutions and isolate hard corona-coated 
nanoparticles. The final amount of nanoparticles present in the pellet was quantified by 175 
measuring their fluorescence with a spectrofluorometer. Afterwards, 200 µg hard corona-coated 
nanoparticles were resuspended in gel loading buffer, boiled for 5 minutes at 95˚C, and loaded 
onto 10% polyacrylamide gel for SDS-PAGE. After electrophoresis, the gel was incubated for 
1 hour with a solution containing 0.1% w/v Coomassie blue R-250 in a water : methanol : 
glacial acetic acid (5:4:1) solution and washed with milliQ water. Pictures were taken with a 180 
ChemiDoc XRS (Biorad, USA). After this, the intensity of selected bands was quantified using 
ImageJ software (http://www.fiji.sc) to evaluate differences in the isolated coronas. 
2.7 mRNA expression of transferrin 
The expression level of transferrin receptor genes TFR1 and TFR2 in brain and liver endothelia 
was determined by RT-PCR. TRP3 or hCMEC/D3 cells were cultured to form a cell barrier as 185 
described above. Then, total mRNA was isolated with a Maxwell instrument and Maxwell 16 
LEV simplyRNA Cells Kit (Promega, Madison, WI, USA) according to the instructions 
provided by the manufacturer. Reverse transcription of mRNA into cDNA was performed with 
a Reverse Transcription System (Promega, Leiden, The Netherlands) in an Eppendorf 
Mastercycler gradient (the following cycle was used: 20˚C for 10 min, 42˚C for 30 min, 20˚C 190 
for 12 min, 99˚C for 5 min and 20˚C for 5 min). The transcription levels were measured by 
quantitative real-time PCR (SensiMix SYBR kit, Bioline, Taunton, MA, USA) in an 
ABI7900HT sequence detection system (Applied Biosystems, Foster City, CA, USA) from 
cDNA (10 ng per sample). The Ct values were obtained with the SDS 2.4 software (Applied 
Biosystems). For each target, four replicates were used, and the average Ct value and its 195 
standard deviation were calculated. Results are expressed as fold-change of the averaged Ct 




Fold change = 2 
–(Mean Ct
TRP3
 – Mean Ct
D3
). 
2.8 Analysis of the rate of endocytosis 
The rate of endocytosis in brain and liver endothelia was determined using dextran as a fluid-200 
phase marker and transferrin as an example of a molecule that follows the route of receptor-
mediated endocytosis. TRP3 and hCMEC/D3 cells were cultured to form a cell barrier as 
described above. Then, cells were incubated for different time periods with 250 µg/ml TRITC 
dextran 10 kDa (Life technologies, NY, USA) dispersed in cell culture medium or with 10 
µg/ml Alexa Fluor 546 fluorescently labeled transferrin (Life Technologies, NY, USA) 205 
dispersed in serum-free medium. Prior to incubation with transferrin, cells were pre-incubated 
with serum-free medium for 20 minutes. After exposure, cells were harvested and analyzed by 
flow cytometry as described above with a 488 nm and 561 nm laser.  At least 15,000 cells were 
acquired per sample, and the median of the obtained cell fluorescence distribution calculated. 
For each exposure time, duplicate samples were made and their median cell fluorescence 210 
intensity is shown, together with their average. The results of an independent replicate 
experiment are shown in Supplementary Figure S5 to confirm the trends observed. 
2.9 Statistical analysis 
For nanoparticle uptake and rate of endocytosis studies, linear regression two-tailed Student’s 
t-test was used as a simple approximation to compare the uptake kinetics between different 215 
samples. For DLS results, an unpaired two-tailed Student‘s t-test was used to determine 
statistically significant differences in the average nanoparticle hydrodynamic diameter after 
dispersion in serum in comparison to the results in PBS. In addition, for qPCR, an unpaired 
two-tailed Student’s t-test was used to determine statistically significant differences in 
expression levels in TRP3 cells in comparison to the results in hCMEC/D3. A p value <0.01 or 220 





3.1 Endothelial cell barrier characterization 
Prior to nanoparticle uptake studies, cell culture conditions were optimized to ensure a proper 
formation of cell barriers. Four immortalized endothelial cell lines derived from different 225 
organs were selected as cell models: hCMEC/D3 (brain), HPMEC-ST1.6R (lung), TRP3 (liver), 
and ciGENC (kidney). To confirm cell barrier formation, the expression and cellular 
distribution of ZO-1, a tight junction protein, and CD31, an adhesion protein that is enriched at 
the basolateral surface of polarized endothelial cell monolayers, were assessed using confocal 
microscopy. As shown in Figure 1A-D, cell monolayers derived from all four cell lines showed 230 
a lateral localization of ZO-1 and CD31, indicating the development of a cell barrier. 
Interestingly, each cell line also showed a unique cell shape and barrier morphology (Figures 
1A-D, left), which suggested that the different endothelia retained at least in part some of their 
organ-specific properties (Krump-Konvalinkova et al., 2001; Parent et al., 2014; Satchell et al., 
2006; Weksler et al., 2005). 235 
3.2 Nanoparticle physicochemical characterization 
Green-labeled 100 nm silica nanoparticles with three different surface functionalizations (SiO2, 
SiO2-NH2, and SiO2-COOH) were selected as nanoparticle models with varying surface 
properties to form different coronas and test uptake preferences in the different endothelial 
barriers. For exposure to cells, the nanoparticles were dispersed in their respective cell culture 240 
media supplemented with 5 mg/ml FBs or human serum. Dynamic light scattering (DLS) was 
used to characterize the stability of the nanoparticle dispersions under these conditions. The 
results confirmed that stable dispersions were obtained for all nanoparticles (Table 1 and Figure 
2). The observed increase in hydrodynamic diameter of nanoparticles when incubated in 
medium containing FBS or human serum confirmed protein adsorption on the surface of 245 




In addition to the hydrodynamic diameter, the zeta potential of the nanoparticles was 
characterized. As expected, plain (SiO2) and carboxylated (SiO2-COOH) silica nanoparticles 
showed negative zeta potential when dispersed in water or PBS (Table 1). For the amino-
modified silica nanoparticles (SiO2-NH2), a negative zeta potential in water and PBS was also 250 
observed. These nanoparticles show a positive zeta potential only at pH below 3.5 (data from 
the manufacturer). As expected (Lesniak et al., 2012; Monopoli et al., 2011), all the 
nanoparticles showed near-neutral zeta potential when incubated in a medium containing FBS 
or human serum, regardless of their surface functionalization (Table 1), as a consequence of 
protein adsorption and corona formation on the surface of nanoparticles. Despite the decrease 255 
in zeta potential absolute value towards neutrality, nanoparticle dispersions remained stable, 
likely due to the steric stabilization by the adsorbed proteins. SDS-PAGE was then used to 
identify the corona proteins on the different nanoparticles (Supplementary Figure S1).  
Quantification of the intensity of selected bands confirmed different coronas were formed, as 
expected due to the different functionalization. However, the banding pattern was relatively 260 
similar across the different samples. 
3.3 Nanoparticle uptake by human endothelial barriers from different organs 
We next investigated the cellular uptake kinetics of the silica nanoparticles in the endothelial 
cell barriers of different organs in order to determine whether there was preferential uptake of 
certain types of nanoparticles by specific endothelial cell types. In addition, we also investigated 265 
whether the uptake was different when the nanoparticles were dispersed in different types of 
serum, bovine or human. It is known that dispersions in different sera can lead to the formation 
of different coronas (Francia et al., 2019; Monopoli et al., 2011; Partikel et al., 2019). SDS-
PAGE of the corona proteins isolated from the surface of the nanoparticles after incubation with 




intensity), confirming that different coronas were formed when nanoparticles were dispersed in 
different sera (Supplementary Figure S1).  
Figures 3 and 4 clearly show that nanoparticle uptake efficiency was different in each barrier 
culture, confirming that, even when cultured in vitro, these cells retain at least in part some of 
the different cellular properties of the organs from which they originated (Figures 3 and 4 for 275 
experiments in bovine or human serum, respectively and Supplementary Figures S2-3 for the 
results obtained in independent replicate experiments). When incubated in FBS, nanoparticles 
accumulated at the highest level in kidney and liver endothelia, followed by lung endothelium, 
and the lowest accumulation was observed in the cells from the blood-brain barrier (Figure 3). 
Similar results were also observed when human serum was used, but with closer uptake levels 280 
in liver and lung endothelia, than in kidney (Figure 4). In addition, the overall uptake efficiency 
for all nanoparticles in all barrier cultures was lower when nanoparticles were incubated in 
human serum, indicating that the serum source also clearly influenced uptake. Similar effects 
were previously observed (Francia et al., 2019; Salvati et al., 2013). After this, as a simple 
approximation, linear fit and statistical analysis were applied to compare the uptake kinetics of 285 
the different nanoparticles for each cell line (see Section 2.9 for details). No differences were 
observed between the different endothelial cell barriers concerning the relative uptake 
efficiencies of the different nanoparticles (Figures 3 and 4). Specifically, statistical analysis 
confirmed that all cell lines showed higher uptake for SiO2-NH2 when dispersed in FBS (Figure 
3), while a higher uptake for SiO2-COOH was observed when nanoparticles were dispersed in 290 
human serum. However, this latter was statistically significant only in the case of the brain 
endothelial cells (Figure 4A). This indicated that changing corona composition by dispersion 
in different sera can affect nanoparticle uptake preference. Similar trends were observed in 
independent replicate experiments (Supplementary Figures S2-3). Additionally, we performed 




compared uptake of negatively-charged DOPG liposomes and zwitterionic DOPC in brain and 
liver endothelium, both in FBS and in human serum (Supplementary Figure S4). The 
zwitterionic liposomes are known to adsorb lower amounts of protein in serum and show lower 
uptake than charged ones (Yang et al., 2020). In line with this, we found that, in both endothelia, 
the uptake kinetics of the two formulations differed, and in all conditions, in the first hours of 300 
exposure, the negatively-charged DOPG liposomes showed significantly higher uptake in 
comparison to the zwitterionic DOPC liposomes, later converging to comparable levels 
(Supplementary Figure S4). Additionally, as also observed with the silica nanoparticles, in all 
cases, uptake was higher when the liposomes were added to cells in mediun with FBS than with 
HS and uptake was higher in liver than in brain endothelium, the effect being more evident for 305 
liposomes dispersed in FBS. 
3.4 Rate of endocytosis of brain and liver endothelia 
As a final step, we investigated whether the observed differences in nanoparticle uptake 
efficiency between the different barrier cultures could be due to differences in their rate of 
endocytosis. For this purpose, we used brain and liver endothelia, which showed the lowest and 310 
highest nanoparticle uptake, respectively. The rate of endocytosis was determined by using 
FITC-dextran 10 kDa as a fluid-phase marker, and transferrin, as an example of a protein which 
is internalized via receptor-mediated endocytosis. Uptake kinetics were determined and linear 
fit applied to statistically compare the trend of uptake rates (see Section 2.9 for details, Figure 
5 and Supplementary Figure S5 for the results obtained in independent replicate experiments). 315 
As shown in Figure 5A, there was no major difference in the uptake rate of FITC-dextran. 
However, the liver endothelium showed much higher transferrin uptake in comparison to brain 
endothelium (Figure 5B). We then investigated whether this was due to a higher expression 
level of the transferrin receptor TFR1. Interestingly, as shown in Figure 5C, we found that the 




However, the expression level of the secondary transferrin receptor TFR2 was shown to be 
three times higher in liver endothelium, possibly explaining the higher transferrin uptake in the 
liver. Overall, these results confirmed that different endothelial cells express cell receptors to 
different levels and show differences in uptake rates. 
4. Discussion 325 
The aim of this study was to investigate the effect of endothelial cell heterogeneity on the 
cellular uptake of nanoparticles. More specifically, we aimed to determine whether by changing 
nanoparticle properties, thus forming different coronas nanoparticles could be targeted to 
specific organs. Previously it has been shown that changing nanoparticle size, charge, or other 
similar parameters can affect nanoparticle distribution in vivo. This may be related to 330 
differences in the type of corona formed and may confer "natural targeting" to organ-specific 
endothelial cells (De Jong et al., 2008; He et al., 2010; Hirn et al., 2011). These effects could 
be exploited for nanomedicine targeting (Blanco et al., 2015). To determine whether this could 
be possible, we chose four unique organ-derived endothelial cell lines: hCMEC/D3 (blood-
brain barrier), HPMEC-ST1.6R (lung microvasculature), TRP3 (liver sinusoid), and ciGENC 335 
(kidney glomerulus). These endothelial cell lines are well characterized immortalized cell lines 
and retain many of their organ-specific properties (Krump-Konvalinkova et al., 2001; Parent et 
al., 2014; Satchell et al., 2006; Weksler et al., 2005). Endothelial cell barriers were formed and 
exposed to silica nanoparticles with three different surface functionalizations in the presence of 
bovine or human serum. Silica nanoparticles, in general, are well characterized and are known 340 
to form stable dispersions in cell medium supplemented with proteins (Lesniak et al., 2012; 
Monopoli et al., 2011; Shapero et al., 2011). Several studies have reported that surface charge 
(among many other nanoparticle properties) affects corona formation and nanoparticle uptake 
into specific cell types (Arvizo et al., 2010; Chithrani et al., 2006; He et al., 2010; Rejman et 




a model system to form different coronas and test potential differences in uptake preferences 
across the different cell types. As expected due to the different surface functionalization, 
quantification of the bands obtianed by SDS-PAGE on the proteins recovered from the three 
nanoparticles confirmed that different coronas were formed (Supplementary Figure S1).  
Flow cytometry was used to measure nanoparticle uptake by cells. Protocols were optimized to 350 
reduce the eventual presence of nanoparticles remaining outside of the cells (see Section 2.5 
for details). Additionally, uptake was measured at multiple time points to determine uptake 
kinetics and compare their rate (this also allows to exclude eventual contribution of residual 
nanoparticles adhering outside cells (Lesniak et al., 2013)). As previously observed, uptake 
levels were much lower in human serum than in FBS, likely due to higher competition for cell 355 
receptors between the nanoparticles and free ligands in serum when human instead of bovine 
serum was used on the human cells, as well as differences in corona compostion in the different 
sera (Supplementary Figure S1) (Francia et al., 2019). When the uptake of the different 
nanoparticle types for each cell type was compared, uptake levels were different. Thus, despite 
having the same size and similar zeta potential after dispersion in serum (Table 1 and Figure 360 
2), the three nanoparticles were taken up by cells at different levels, as expected because of 
their different functionalization and corona (Supplementary Figure S1). However, the three 
nanoparticles were taken up by the various endothelial barrier models following similar trends: 
in fact, it was found that for all cell types, when the nanoparticles were dispersed in FBS, the 
uptake was higher for SiO2-NH2 (also confirmed by statistical analysis on the uptake rates, see 365 
Figure 3). For nanoparticles in human serum, however, a higher uptake was observed for SiO2-
COOH and the effect was only statistically significant in the brain endothelium (Figure 4). A 
possible interpretation of the similar uptake preferences among the different types of 
endothelial cells is that the degree of functionalization of these nanoparticles was not very high. 




functionalization to study in detail how the degree of functionalization affects the nanoparticle 
corona, thus also uptake by cells. Nevertheless, uptake preferences changed dramatically when 
the nanoparticles were incubated with either FBS or human serum. It is known that corona 
proteins can mediate recognition and interaction of nanoparticles with cell receptors (Francia 
et al., 2020, 2019; Lara et al., 2018, 2017; Nel et al., 2009; Salvati et al., 2013). Thus, the 375 
different uptake preferences observed are likely due to differences in the protein corona 
composition on the nanoparticles when incubated with FBS or human serum (as indeed we 
show in Supplementary Figure S1). This supports the overall hypothesis that tuning the corona 
composition on a nanoparticle (for instance by changing nanomaterial properties such as size, 
charge, composition or by pre-forming artificial coronas) can be used as a strategy to modulate 380 
uptake preferences in different cell types, thus potentially allowing a preferential targeting of 
nanoparticles to specific organs in vivo. Additionally the results from our studies have shown 
that even small changes in a single type of nanoparticle can affect its uptake in endothelial cells 
from different locations in the body. These studies indicate that much needs to be done to 
determine how and if size, shape, chemical composition etc. influence the uptake of 385 
nanoparticles. Nanoparticles of different size or material could also be used to form different 
coronas and test similar effects, as indeed we observed here using liposomes of different charge 
(Supplementary Figure S4). Another important observation is that despite the similar uptake 
preferences observed by certain types of nanoparticles, nanoparticle uptake efficiency differed 
strongly in the different endothelial barrier models. Thus, in agreement with common 390 
observations for in vivo distribution studies with silica and other nanoparticles, kidney and liver 
endothelia showed a higher uptake, possibly related to the physiological role of these organs in 
excretion (De Jong et al., 2008; Gromnicova et al., 2016; Waegeneers et al., 2018; Wilhelm et 
al., 2016). In contrast, the blood-brain barrier, known to be the tightest of the endothelial 




nanoparticles. In agreement with this, lower nanoparticle uptake in the brain is also commonly 
observed in vivo (De Jong et al., 2008; Gromnicova et al., 2016; Semete et al., 2010). Similar 
results were observed by Gromnicova et al., who showed that the internalization of gold 
nanoparticles was significantly higher in kidney than in brain endothelium (Gromnicova et al., 
2016). The differences in uptake efficiency could also be a reflection of differences in their rate 400 
of endocytosis. In line with this, we showed that while the rate of endocytosis of a fluid-phase 
marker (FITC-dextran 10 kDa) in liver and brain endothelium was comparable, the uptake of 
transferrin, here selected as an example to compare the rate of a receptor-mediated uptake in 
the two cell types, was much higher in the liver (Figure 5). Since corona-coated nanoparticles 
are known to be internalized via active processes, and in several cases, it has been shown that 405 
uptake occurs after interaction with cell receptors (Francia et al., 2020; Lara et al., 2018, 2017), 
the higher nanoparticle uptake in liver endothelium in comparison with brain endothelium is 
likely connected to similar differences in receptor activity among the different endothelia. 
Interestingly, the uptake rate of transferrin and the expression level of transferrin receptor TFR1 
were inversely related between liver and brain endothelium. Since TFR1 is known to be the 410 
main receptor for transferrin, it is possible that despite the lower expression level in liver 
endothelium, this receptor is recycled faster in liver endothelium than in brain endothelium. In 
addition, the higher expression level of the secondary transferrin receptor TFR2 in liver 
endothelium could also contribute to the higher uptake of transferrin. These results suggest that 
differences in receptor expression and activity, rather than the basal rate of (fluid-phase) 415 
endocytosis, may potentially determine the differences observed in the uptake efficiency of 
nanoparticles. Thus, it would be interesting to identify the receptors involved in the uptake of 
these specific nanoparticles and compare their expression and activity in the different cell types. 
It is also important to note that in order to use the same protein content for corona formation, 




endothelia, but using different basal media, as required for each cell type. Previous studies have 
shown that even when using the same serum and nanoparticles, the use of different cell culture 
media could affect protein corona formation, and, consequently, uptake by cells (Maiorano et 
al., 2010; Strojan et al., 2017). However, here, three out of the four endothelia (brain, lung and 
kidney endothelia) were cultured using the same basal media and only some supplements 425 
differed. Thus, the observed uptake differences were most likely due to the heterogeneity of 
each endothelia, rather than these subtle differences in the media. More importantly, the 
different endothelial barrier models showed differences in uptake efficiency, which reflected 
the different physiological functions of the various organs from which they originated. These 
results suggested that the in vitro models generated with the different cell lines retained a high 430 
degree of the distinctive features present in the endothelia of the organ type.  
5. Conclusion 
The results from the present study confirm that the heterogeneity of endothelial cells clearly 
influences the uptake of nanoparticles by different organs. Since most drugs lack specificity for 
endothelial cells, the ability to effectively target specific endothelial cells using nanoparticles 435 
could offer significant benefits for future clinical applications. Our findings highlight the 
importance of exploiting further endothelial cell heterogeneity for better design of targeted drug 
carriers. Identification of relevant receptors to enable selective uptake by specific endothelial 
cell types may provide valuable information for improving the design of such carriers. In 
addition to the genotypic and phenotypic profiling of endothelial cell types, the identification 440 
of relevant receptors for targeted nanomedicine may be deduced from the protein corona 
composition of nanoparticles that show preferential interaction with the cell type of choice 
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Figure 1. Morphology, ZO-1, and CD31 expression in endothelial barriers derived from 
different organs. Endothelial barriers were prepared as described in the Methods. Left: light 
microscopy images of the endothelial barriers (scale bar: 50 μm). Right: confocal images of 
anti-ZO-1 (red) and anti-CD31 (green) immunostainings. Blue: DAPI stained nuclei (scale bar: 






Figure 2. Size distribution by intensity (diameter, d, nm) of 100 nm SiO2 (A), SiO2-NH2 (B), 
and SiO2-COOH (C) as obtained by dynamic light scattering (DLS). Silica nanoparticles (100 
μg/ml) were dispersed in dH2O, PBS, and EBM-2 cell culture medium supplemented with 5 660 
mg/ml of FBS or human serum (HS). All nanoparticles remained stable after dispersion in the 






Figure 3. Nanoparticle uptake levels in endothelial barriers derived from different organs in 665 
the presence of bovine serum. Median cell fluorescence intensity as obtained by flow cytometry 
of hCMEC/D3 (A), HPMEC-ST1.6R (B), TRP3 (C), and ciGENC (D) exposed to different 
nanoparticles. Endothelial barriers were prepared as described in the Methods and exposed to 
50 μg/ml of 100 nm SiO2, SiO2-NH2, or SiO2-COOH in a cell culture medium supplemented 
with 5 mg/ml FBS for the indicated times. The median cell fluorescence intensity of two 670 
replicate samples is shown, together with their mean (indicated with a line connecting the mean 
of each time point). The results of an independent replicate experiment are shown in 
Supplementary Figure S2. For each uptake kinetics, a linear regression two-tailed Student’s t-
test was applied to compare them (see Section 2.9 for details). Statistically significant 







Figure 4. Nanoparticle uptake levels in endothelial cells derived from different organs in the 
presence of human serum. Median cell fluorescence intensity as obtained by flow cytometry of 680 
hCMEC/D3 (A), HPMEC-ST1.6R (B), TRP3 (C), and ciGENC (D) exposed to different 
nanoparticles. Endothelial barriers were prepared as described in the Methods and exposed to 
50 μg/ml 100 nm SiO2, SiO2-NH2, or SiO2-COOH in a cell culture medium supplemented with 
5 mg/ml human serum for the indicated times. The median cell fluorescence intensity of two 
replicate samples is shown, together with their mean (indicated with a line connecting the mean 685 
of each time point). The results of an independent replicate experiment are shown in 
Supplementary Figure S3. For each uptake kinetics, a linear regression two-tailed Student’s t-
test was applied to compare them (see Section 2.9 for details). Statistically significant 
differences are indicated with an asterisk. p ≤ 0.05 was considered significant.  






Figure 5. Rates of endocytosis and expression levels of transferrin receptors in liver and brain 
endothelial barriers. Median cell fluorescence intensity as obtained by flow cytometry of 
hCMEC/D3 and TRP3 barriers exposed to different fluorescent molecules. Endothelial barriers 695 
were prepared as described in the Methods and exposed to 250 µg/ml TRITC dextran 10 kDa 
in cell culture medium (A) or 10 µg/ml Alexa Fluor546 fluorescently labeled transferrin (B) in 
serum-free medium for the indicated times. The median cell fluorescence intensity of two 
replicate samples is shown, together with their mean (indicated with a line connecting the mean 
of each time point). The results of an independent replicate experiment are shown in 700 
Supplementary Figure S4. For each uptake kinetics, a linear regression two-tailed Student’s t-
test was applied to compare them (see Section 2.9 for details). Statistically significant 
differences are indicated with an asterisk. p ≤ 0.05 was considered significant. C: expression 
levels of genes coding for the transferrin receptors TFR1 and TFR2 in TRP3 in comparison to 
hCMEC/D3. The results are average and standard deviation over four technical replicates of 705 
the fold-change in gene expression levels in TRP3 normalized to the expression levels in 
hCMEC/D3, calculated as detailed in the Methods (C). An unpaired two-tailed student‘s t-test 
was used to determine statistically significant difference compared to the expression level in 
hCMEC/D3 cells (see Section 2.9 for details). Statistically significant differences are indicated 
with an asterisk (*p < 0.05 n = 4).  710 
 
 
